Edition:
United States

LivaNova PLC (LIVN.OQ)

LIVN.OQ on NASDAQ Stock Exchange Global Select Market

84.00USD
21 May 2018
Change (% chg)

-- (--)
Prev Close
$84.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
150,289
52-wk High
$92.19
52-wk Low
$56.33

Latest Key Developments (Source: Significant Developments)

Livanova To Acquire Tandemlife
Wednesday, 14 Feb 2018 08:13pm EST 

Livanova Plc ::LIVANOVA TO ACQUIRE TANDEMLIFE.LIVANOVA TO ACQUIRE TANDEMLIFE.LIVANOVA PLC - LIVANOVA HAS AGREED TO PAY UP TO $250 MILLION FOR TANDEMLIFE.LIVANOVA PLC - DEAL IS PROJECTED TO BE MODESTLY ACCRETIVE IN 2018 AND IS EXPECTED TO CLOSE IN FIRST HALF OF 2018.LIVANOVA PLC - UPFRONT COSTS FOR DEAL TOTAL $200 MILLION, WITH UP TO $50 MILLION IN CONTINGENT CONSIDERATIONS BASED ON REGULATORY MILESTONES.LIVANOVA PLC - ‍UPFRONT COSTS RELATED TO DEAL TOTAL $200 MILLION, WITH UP TO $50 MILLION IN CONTINGENT CONSIDERATIONS BASED ON REGULATORY MILESTONES​.  Full Article

Livanova Initiates Believe Aortic Heart Valve Study In The U.S., Canada
Thursday, 11 Jan 2018 09:00am EST 

Jan 11 (Reuters) - Livanova Plc ::LIVANOVA INITIATES BELIEVE AORTIC HEART VALVE STUDY IN THE U.S. AND CANADA.LIVANOVA PLC - THE BELIEVE STUDY IS EXPECTED TO ENROLL ABOUT 230 PATIENTS AT 15 SITES FROM U.S. AND CANADA.  Full Article

Livanova To Acquire Imthera Medical
Tuesday, 5 Dec 2017 03:01am EST 

Dec 5 (Reuters) - Livanova Plc ::LIVANOVA TO ACQUIRE IMTHERA MEDICAL, INC..LIVANOVA PLC SAYS ENTERED INTO AN AGREEMENT TO ACQUIRE REMAINING OUTSTANDING INTERESTS IN IMTHERA MEDICAL, INC..LIVANOVA PLC SAYS HAS AGREED TO PAY UP TO APPROXIMATELY $225 MILLION TO ACQUIRE REMAINING OUTSTANDING INTERESTS OF IMTHERA.LIVANOVA PLC SAYS DEAL IS PROJECTED TO BE NEAR-TERM ACCRETIVE AND IS EXPECTED TO CLOSE IN EARLY 2018.LIVANOVA PLC SAYS UP-FRONT COSTS FOR THE DEAL ARE APPROXIMATELY $78 MILLION WITH BALANCE PAID ON A SCHEDULE DRIVEN BY REGULATORY AND SALES MILESTONES.  Full Article

LivaNova says breaching co to pay $6 mln if deal with Microport collapses
Monday, 20 Nov 2017 06:40am EST 

Nov 20 (Reuters) - Microport Scientific Corp <0853.HK>:LivaNova - If deal to sell co's cardiac rhythm management business to Microport Cardiac Rhythm terminated‍, breaching party to pay termination fee of $6 million.  Full Article

Microport Scientific's unit buys CRM business from Livanova
Monday, 20 Nov 2017 03:31am EST 

Nov 20 (Reuters) - Microport Scientific Corp <0853.HK>::Announces ‍acquisition of CRM business from Livanova PLC​.‍Unit buys CRM business for initial consideration of US$190 million​ from Livanova PLC.  Full Article

LivaNova Plc reports ‍Q3 diluted earnings per share were $0.57​
Thursday, 2 Nov 2017 07:00am EDT 

Nov 2 (Reuters) - LivaNova Plc :LivaNova Plc - ‍Q3 2017 diluted earnings per share were $0.57​.LivaNova Plc - ‍Q3 2017 adjusted diluted earnings per share were $0.93​.LivaNova Plc - ‍Reiterates that worldwide net sales for full-year 2017 will remain between 1 and 3 percent growth on a constant currency basis​.LivaNova Plc - ‍Adjusted diluted earnings per share projections for full-year 2017 are now expected to be in range of $3.30 to $3.45​.LivaNova Plc - Qtrly ‍net sales $309.7 million versus $295.3 million​.Q3 earnings per share view $0.78, revenue view $300.5 million -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $3.25 -- Thomson Reuters I/B/E/S.  Full Article

Livanova receives FDA approval for Vagus Nerve Stimulation Therapy system​
Monday, 9 Oct 2017 08:00am EDT 

Oct 9 (Reuters) - Livanova Plc ::Livanova receives FDA approvals for SenTiva device and next-generation VNS therapy programming system for treatment of epilepsy.Says received U.S. FDA approvals for Vagus Nerve Stimulation Therapy system​.  Full Article

Livanova and Microport announce approval of Rega pacemakers by China FDA
Wednesday, 27 Sep 2017 12:07pm EDT 

Sept 27 (Reuters) - Livanova Plc : :Livanova and Microport announce the approval of Rega pacemakers by the China Food and Drug Administration.Livanova - ‍CO, Microport Scientific's JV Microport Sorin Cardiac Rhythm Management obtained approval for family of Rega pacemakers from China FDA.  Full Article

Livanova announces U.S. Launch of Optiflow Arterial Cannulae Family
Monday, 25 Sep 2017 11:24am EDT 

Sept 25 (Reuters) - Livanova Plc ::Says ‍received FDA 510(k) clearance for U.S. Market launch of its Optiflow Arterial Cannulae Family​.  Full Article

LivaNova ‍expects to achieve revenue growth in mid-single-digits in near term and high-single-digits in long term​
Thursday, 14 Sep 2017 04:27pm EDT 

Sept 14 (Reuters) - LivaNova Plc :LivaNova Plc - ‍Expects to achieve revenue growth in mid-single-digits in near term and high-single-digits in long term​.LivaNova Plc - ‍Anticipates compounded annual earnings per share growth in low- to mid-teens from 2017 to 2022​.  Full Article

BRIEF-LivaNova PLC Reports Qtrly Diluted Earnings Per Share From Continuing Operations $0.36

* LIVANOVA PLC - QTRLY WORLDWIDE SALES FROM CONTINUING OPERATIONS $250.4 MILLION, UP 5.3 PERCENT ON CONSTANT CURRENCY BASIS VERSUS Q1 2017

No consensus analysis data available.